arrow
C

Charlotte Domblides

Institut national de la santé et de la recherche médicale
H指数:18
被引数:1,579

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunosuppressive myeloid cells induce mesenchymal-like breast cancer stem cells by a membrane-bound TGF-β1-dependent mechanism

免疫抑制性髓系细胞通过膜结合TGF-β1依赖机制诱导间充质样乳腺癌干细胞

2026-06-010
PRE
Radiological, Radiomics, and Metastatic Patterns Associated with Targetable Oncogenic Drivers on CT-Scan of Newly Diagnosed NSCLC Patients: A Comprehensive Radiogenomics Review

新诊断的NSCLC患者ct扫描中与可靶向致癌驱动因素相关的放射学,放射组学和转移模式: 全面的放射基因组学综述

Cancers
IF4.4
2026-01-310
OAAI
French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases

法国关于在慢性风湿性炎症疾病靶向治疗开始前评估和管理癌症风险的建议

2025-07-120
OA
Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational study

免疫检查点抑制剂诱导的炎症性关节炎的消退,同时维持检查点抑制剂的积极治疗及其停药后: 一项观察性研究

2025-01-010
PRE
Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis

严重免疫相关不良事件后免疫检查点抑制剂再激发的安全性: 回顾性分析

2024-07-080
OAAI
Human NLRC4 expression promotes cancer survival and associates with type I interferon signaling and immune infiltration
2024-04-231
OAAI
Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events
2021-11-0157
OA
Human γδ T cell sensing of AMPK-dependent metabolic tumor reprogramming through TCR recognition of EphA2
2021-07-2930
PRE